Press Releases Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Market Closed - Nasdaq Other stock markets 21:00:00 21/06/2024 BST			Pre-market 13:19:15
3.15 ^USD	+3.28%		5.56	+76.51%

01:54pm	Top Premarket Gainers	MT
01:36pm	ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ALIM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to Shareholders	12:55pm	BU
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences	11:51am	AQ
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	06-04	AQ
Alimera Sciences: Q1 Earnings Snapshot	05-14	AQ
Alimera Sciences Reports First Quarter 2024 Results	05-14	AQ
Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences	05-07	AQ
Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update	04-30	AQ
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03-20	AQ
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	03-19	AQ
Alimera Sciences: Q4 Earnings Snapshot	03-07	AQ
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results	03-07	AQ
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update	02-29	AQ
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®	02-08	AQ
Alimera Completes Recruitment for the Synchronicity Study	01-04	AQ
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	01-02	AQ
Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	12-12	AQ
Alimera Appoints Maggie A. Pax to Its Board of Directors	11-08	AQ
Alimera Announces Scientific Data Highlighting ILUVIEN® To Be Presented at the American Academy of Ophthalmology	31/10/23	AQ
Alimera Sciences: Q3 Earnings Snapshot	26/10/23	AQ
Alimera Sciences Reports Third Quarter 2023 Results	26/10/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Press Releases

Filters